Linde's Margin Pivot: Lincare Under Review as Record Backlog Points to Electronics & Space
Strong top-line and record $8.1B backlog mask a margin miss driven by U.S. homecare; strategic options now on the table.
LIN · Earnings Call · 2026-07-31
Margin Miss Meets Strategic Re-Evaluation
Linde delivered record sales ($9.3B, +9% Y/Y) and EPS ($4.50, +10%) in Q2 2026, yet the narrative quickly shifted to margins. Operating margins declined 60 bps Y/Y, or 30 bps excluding cost pass-through, driven primarily by the U.S. homecare business (Lincare). Management was unusually direct about the drag: “We are not satisfied with our margin performance for this quarter.” — Sanjiv Lamba, Chief Executive Officer · 2026-07-31 The company has been pruning Lincare for several quarters, but this call escalated the language to a full strategic review. Sanjiv Lamba stated:This is a notable departure from prior quarters, where the tone was focused on operational improvement rather than potential divestiture. In the May 2026 call, Lamba had only noted “trimming that portfolio” and leveraging technology – no mention of strategic options. The shift suggests management may be more willing to part with the business if improvement actions don't deliver.At the same time, we continue to evaluate the strategic fit of this U.S. homecare business within Linde, both in part and as a whole.
The margin pressure is partly a mix effect. Hard goods sales in the U.S. are up double-digit – a sign of manufacturing recovery – but these are margin-dilutive. Management framed this as temporary and constructive. Still, the market has taken notice: the stock is down ~10.8% from its July 2 high, and the 90-day trend is negative. Operating margin sits at 27.8% for Q1 2026, down from 28.4% in Q4 2025, and the full history shows a peak of 30.6% in 2018. The market is clearly questioning the quality of earnings even as revenue and EPS grow.
Electronics & Space Power the Backlog
The growth engine remains the project backlog, which hit a record $8.1B (sale-of-gas) after adding $1B of new electronics wins. Sanjiv highlighted: “we added $1 billion of new electronic wins to the backlog to support the expansion of advanced node fabs in the Western US.” — Sanjiv Lamba, Chief Executive Officer · 2026-07-31 These wins support the narrative that electronics wins will drive a 8-handle backlog exit for the year, offsetting ~$1.3B of project startups. The electronics momentum is broad-based across the US, Taiwan, Korea, and China.Commercial space is also becoming a more visible capex driver. The company increased its 2026 capex estimate by ~$500M, partly for space-related base capex. CFO Matthew White noted: “there are going to be more commercial space activities in the base CAPEX that also are contributing to that as well.” — Matthew J. White, Chief Financial Officer · 2026-07-31 This follows earlier commentary that space is a “billion-dollar opportunity” by 2030, and the company is building out infrastructure in Texas and Florida. While space is still too small to move the needle, it adds a long-duration growth overlay.
Helium remains a swing factor. The Middle East conflict (including the Strait Of Hormuz) has disrupted supply, but management has secured long-term contracts and expects normalization into next year. As Matthew White said in the prior call: “Separately, our volumes are up, and we have actually already secured some long-term agreements.” — Matthew White, Chief Financial Officer · 2026-05-01 In this quarter, helium pricing is improving, but dislocation costs are dilutive to margins near-term. The unchanged guidance suggests management sees balance, but any further escalation in the Strait could tip the balance.
Overall, Linde is executing well on its core algorithm – backlog conversion, price discipline, and productivity – but the Lincare drag and temporary mix effects are testing investor patience. The decision to evaluate strategic options for Lincare, coupled with record backlog and rising capex for space and electronics, signals a portfolio in transition. Whether the margin story recovers – and whether Lincare becomes a divestiture – will be key to the next leg of the stock.